Teva introduces ProAir Digihaler inhalation powder for asthma and COPD
Teva Pharmaceutical Industries Ltd. - On Thursday May 12, Doug Sommerville General Manager Teva Canada, John Jacobs GM for Teva Canada Innovation, Ben Gray VP, General Counsel, Bennett Lee and Houri Ohan
Teva Canada Announces Product Availability of AJOVY™ | Nasdaq
Teva Canada Charts a New Prescription for Care | Business Wire
Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
BASANT SINGH YADAV - Pilot Researcher-I - Teva Active Pharmaceutical Ingredients | LinkedIn
Teva Pharmaceutical Industries Ltd. - Test, test, and test again. Lisa Cameron and the Quality team at Teva Canada have their eyes on every angle of product quality to ensure our medicines
Class not certified for abstract (“what if?”) harm respecting increased risk of cancer diagnosis: Palmer v. Teva Canada Ltd., 2022 ONSC 4690 | Alexander Holburn Beaudin + Lang LLP
Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News